Anabel Sorolla Bardaji
Grau: Doctor/a
asorolla(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/E-2546-2012
Publicacions
-
Shrestha S; Sorolla A; Fromont J; Blancafort P; Flematti GR
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells.
Marine Drugs 16 -. .
-
Shrestha S; Sorolla A; Fromont J; Blancafort P; Flematti GR
Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells.
Marine Drugs 16 -. .
-
Tonks ID; Mukhopadhyay P; Schroder WA; Sorolla A; Mould AW; Handoko HY; Ferguson B; Muller HK; Keith P; Hayward NK; Walker GJ; Kay GF
Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.
ONCOGENE 36 3789-3795. .
-
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Oncotarget 7 60535-60554. .
-
Sorolla A; Ho D; Wang E; Evans CW; Ormonde CF; Rashwan R; Singh R; Iyer KS; Blancafort P
Sensitizing basal-like breast cancer to chemotherapy using nanoparticles conjugated with interference peptide.
Nanoscale 8 9343-9353. .
-
Senft D; Sorolla A; Dewing A; Claps G; Lau E; Walker GJ; Ronai ZA
ATF2 alters melanocyte response and macrophage recruitment in UV-irradiated neonatal mouse skin.
PIGMENT CELL & MELANOMA RESEARCH 28 481-484. .
-
Sorolla A; Tallack MR; Oey H; Harten SK; Daxinger LC; Magor GW; Combes AN; Ilsley M; Whitelaw E; Perkins AC
Identification of novel hypomorphic and null mutations in Klf1 derived from a genetic screen for modifiers of a-globin transgene variegation.
GENOMICS 105 116-122. .
-
Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X
Antioxidants Impair Anti-Tumoral Effects of Vorinostat, but Not Anti-Neoplastic Effects of Vorinostat and Caspase-8 Downregulation
PLOS ONE 9 -. .
-
Bergadà L; Sorolla A; Yeramian A; Eritja N; Mirantes C; Matias-Guiu X; Dolcet X
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
MOLECULAR ONCOLOGY 7 763-775. .
-
Daxinger L; Harten SK; Oey H; Epp T; Isbel L; Huang E; Whitelaw N; Apedaile A; Sorolla A; Yong J; Bharti V; Sutton J; Ashe A; Pang Z; Wallace N; Gerhardt DJ; Blewitt ME; Jeddeloh JA; Whitelaw E
An ENU mutagenesis screen identifies novel and known genes involved in epigenetic processes in the mouse.
GENOME BIOLOGY 14 -. .
-
Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier
Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
MOLECULAR ONCOLOGY 6 530-541. .
-
MARTI LABORDA, ROSA MARIA; Sorolla A; Yeramian A
New therapeutic targets in melanoma.
ACTAS DERMO-SIFILIOGRAFICAS 103 579-590. .
Projectes
- Simultaneous targeting the partners in crime MYC and BRD4 in triple negative breast cancer
- DEVELOPMENT OF PRECISION THERAPIES FOR TRIPLE NEGATIVE BREAST CANCERS BASED ON CRISPR/CAS9 RIBONUCLEOPROTEINS.
- Ajuts contractació personal investigador predoctoral en formació (FI2022)
- Development of precision therapies for triple negative breast cancer based on CRISPR/Cas12a ribonucleoproteins
- Contrato Miguel Servet - Proyecto + RRHH
- EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
- Diseño y testaje de péptidos de interferencia para el tratamiento del cáncer de mama triple negativo
